Wednesday, May 9, 2007

Sciele Pharma to sell $285 million in new debt

(Reuters) - The company said it intends to use the proceeds of the offering to redeem all of its $150 million 1.75 percent contingent convertible senior subordinated notes due in 2024, and for acquisitions or licenses of products and technologies, and for capital expenditures and general corporate purposes.




Read more at Reuters.com Bonds News

No comments: